The smallest likely pathogenic duplication of a SOX9 enhancer identified to date in a family with 46,XX testicular differences of sex development

Am J Med Genet A. 2023 Dec;191(12):2831-2836. doi: 10.1002/ajmg.a.63367. Epub 2023 Aug 8.

Abstract

Copy number variants that duplicate distal upstream enhancer elements of the SOX9 gene cause 46,XX testicular differences of sex development (DSD) which is characterized by a 46,XX karyotype in an individual presenting with either ambiguous genitalia or genitalia with varying degrees of virilization, including those resembling typical male genitalia. Reported duplications in this region range in size from 24 to 780 kilobases (kb). Here we report a family with two affected individuals, the proband and his maternal uncle, harboring a 3.7 kb duplication of a SOX9 enhancer identified by clinical genome sequencing. Prior fluorescence in situ hybridization (FISH) for SRY and a multi-gene panel for ambiguous genitalia were non-diagnostic. The unaffected mother also carries this duplication, consistent with previously described incomplete penetrance. To our knowledge, this is the smallest duplication identified to-date, most of which resides in a 5.2 kb region that has been previously shown to possess enhancer activity that promotes the expression of SOX9. The duplication was confirmed by quantitative-PCR and shown to be in tandem by bidirectional Sanger sequencing breakpoint analysis. This finding highlights the importance of non-coding variant interrogation in suspected genetic disorders.

Keywords: 46,XX testicular differences of sex development; SOX9; duplication; enhancer.

Publication types

  • Case Reports

MeSH terms

  • Disorders of Sex Development* / genetics
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Mothers
  • Regulatory Sequences, Nucleic Acid*
  • SOX9 Transcription Factor / genetics
  • Sexual Development

Substances

  • SOX9 protein, human
  • SOX9 Transcription Factor